← All organizations

Highest phase reached
Phase 3
Timeline
2010s
- Jun 1, 2013
scPharmaceuticals, Inc.— Founded
2020s
- Oct 7, 2022
furosemide— Marketing Organization
- Oct 7, 2022
furosemide— NDA Secondary Org
Drugs by trial phase (2 distinct, 12 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (1)
Recent trials (13)
- NCT06167707Lead sponsorPhase 1Apr 15, 2024
- NCT05528588CollaboratorPhase 2Jan 31, 2023
- NCT04593823Lead sponsorPhase 2Mar 31, 2021
- NCT04161482Lead sponsorPhase 1Nov 30, 2019
- NCT03458325Lead sponsorPhase 3Jun 30, 2019
- NCT02804035Lead sponsorPhase 2Jul 1, 2016
- NCT02804282Lead sponsorPhase 3Jul 1, 2016
- NCT02721511CollaboratorPhase 1/Phase 2May 1, 2016
- NCT02579057CollaboratorPhase 2/Phase 3Feb 1, 2016
- NCT02561442Study directorPhase 2/Phase 3Oct 1, 2015
- NCT02561442Lead sponsorPhase 2/Phase 3Oct 1, 2015
- NCT02329834Lead sponsorPhase 2/Phase 3Apr 1, 2015
- NCT02350725Lead sponsorPhase 1/Phase 2Dec 1, 2014
Details
- Founded
- Burlington, MA, US Jun 1, 2013
- Last known activity
- Apr 15, 2024